168 related articles for article (PubMed ID: 21705481)
1. Epigenetic regulation of cellular adhesion in cancer.
Katto J; Mahlknecht U
Carcinogenesis; 2011 Oct; 32(10):1414-8. PubMed ID: 21705481
[TBL] [Abstract][Full Text] [Related]
2. Cancer epigenetics.
Taby R; Issa JP
CA Cancer J Clin; 2010; 60(6):376-92. PubMed ID: 20959400
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
4. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer.
Sharma A; Heuck CJ; Fazzari MJ; Mehta J; Singhal S; Greally JM; Verma A
Wiley Interdiscip Rev Syst Biol Med; 2010; 2(6):654-69. PubMed ID: 20890963
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic changes in cancer.
Grønbaek K; Hother C; Jones PA
APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
[TBL] [Abstract][Full Text] [Related]
7. A new paradigm in toxicology and teratology: altering gene activity in the absence of DNA sequence variation.
Reamon-Buettner SM; Borlak J
Reprod Toxicol; 2007 Jul; 24(1):20-30. PubMed ID: 17596910
[TBL] [Abstract][Full Text] [Related]
8. [Epigenome and cancer: new possibilities of cancer prevention and therapy?].
Paluszczak J; Baer-Dubowska W
Postepy Biochem; 2005; 51(3):244-50. PubMed ID: 16381168
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics and cancer: implications for drug discovery and safety assessment.
Moggs JG; Goodman JI; Trosko JE; Roberts RA
Toxicol Appl Pharmacol; 2004 May; 196(3):422-30. PubMed ID: 15094313
[TBL] [Abstract][Full Text] [Related]
10. Targeting DNA methylation in cancer.
Szyf M
Bull Cancer; 2006 Sep; 93(9):961-72. PubMed ID: 16980240
[TBL] [Abstract][Full Text] [Related]
11. Aberrant epigenetic landscape in cancer: how cellular identity goes awry.
Berdasco M; Esteller M
Dev Cell; 2010 Nov; 19(5):698-711. PubMed ID: 21074720
[TBL] [Abstract][Full Text] [Related]
12. [Master and servant: epigenetic deregulations as a cause and a consequence of cancer].
Laget S; Defossez PA
Med Sci (Paris); 2008; 24(8-9):725-30. PubMed ID: 18789219
[TBL] [Abstract][Full Text] [Related]
13. [Epigenetics and cancer].
Deltour S; Chopin V; Leprince D
Med Sci (Paris); 2005 Apr; 21(4):405-11. PubMed ID: 15811306
[TBL] [Abstract][Full Text] [Related]
14. [Epigenetics-related diseases and analytic methods].
Soejima H
Rinsho Byori; 2009 Aug; 57(8):769-78. PubMed ID: 19764412
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic gene regulation in cancer.
Ballestar E; Esteller M
Adv Genet; 2008; 61():247-67. PubMed ID: 18282509
[TBL] [Abstract][Full Text] [Related]
16. Interplay between different epigenetic modifications and mechanisms.
Murr R
Adv Genet; 2010; 70():101-41. PubMed ID: 20920747
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the cancer imprintome.
Monk D
Brief Funct Genomics; 2010 Jul; 9(4):329-39. PubMed ID: 20551091
[TBL] [Abstract][Full Text] [Related]
18. Epigenetics in disease and cancer.
Choo KB
Malays J Pathol; 2011 Dec; 33(2):61-70. PubMed ID: 22299205
[TBL] [Abstract][Full Text] [Related]
19. Histone modifications and cancer.
Sawan C; Herceg Z
Adv Genet; 2010; 70():57-85. PubMed ID: 20920745
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic biomarkers for human cancer: the time is now.
Mulero-Navarro S; Esteller M
Crit Rev Oncol Hematol; 2008 Oct; 68(1):1-11. PubMed ID: 18430583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
